https://www.selleckchem.com/pr....oducts/dapansutrile.
26, 95% CI 0.12-0.60, P = 0.001), whereas 8 studies comparing extended systemic antibiotics with standard of care found no statistical significance (RR = 0.80, 95% CI 0.60-1.08, P = 0.13). Conclusions In the setting of IBR following mastectomy, there is insufficient evidence for the use of extended prophylactic antibiotics to reduce SSI rates. Well-designed randomized controlled trials in patients undergoing IBR should be conducted to determine the appropriate regimen and/or duration of prophylactic antibiotics on SSI outcomes. Cop
Like
Comment
Share
